Biogen Idec Czech Republic

Last updated: 13.02.2014

Address: Na Pankráci 1683/127 140 00 Praha 4,Czech Republic

Tel: +420 255 706 200


Company description

Biogen Idec is a Fortune 500 company and global biotechnology leader that generates more than $5 billion in annual revenues. Our mission is to discover, develop and deliver innovative therapies for the treatment of neurodegenerative diseases, hemophilia, and immunology to patients worldwide through cutting-edge science and medicine. Our robust product pipeline is supported by one of the industry’s leading capacities for biologics manufacturing, featuring nearly 200,000 liters of bioreactor capacity.

We have more than 5,000 employees worldwide and a direct commercial presence in more than 29 markets and a network of distribution partners in more than 70 additional markets, including emerging markets such as Central and Eastern Europe, Brazil, China and India. We pursue our mission through a strategic combination of internal research and development and through partnerships, alliances, and acquisitions.

With an unshakeable commitment to our mission and values, we expect to build shareholder value by bringing meaningful therapies to patients with serious, unmet medical needs.

Biogen Idec has had an affiliate in the Czech market since 2006.

Products and services

Today, Biogen Idec is the oldest independent biotechnology company in the world. Patients worldwide benefit every day from its industry leading multiple sclerosis (MS) products. The company’s R&D efforts are focused on bringing new therapies to market for patients with neurodegenerative diseases, autoimmune disorders and hemophilia.



We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here